about
Randomized clinical trial: effect of the 5-HT4 receptor agonist revexepride on reflux parameters in patients with persistent reflux symptoms despite PPI treatment.Efficacy and Safety of Prucalopride in Chronic Constipation: An Integrated Analysis of Six Randomized, Controlled Clinical Trials.Therapeutic enteroscopy using a new single-balloon enteroscope: a case series.Endoscopic submucosal dissection specimens in early colorectal cancer: lateral margins, macroscopic techniques, and possible pitfalls.Gastrointestinal risk assessment in patients requiring non-steroidal anti-inflammatory drugs for osteoarthritis: The GIRANO study.Management of long post-radiation esophageal strictures by means of endoscopic submucosal dissectionFCGR polymorphisms and cetuximab efficacy in chemorefractory metastatic colorectal cancer: an international consortium study.P-THER-16: Diagnostic and therapeutic role of endoscopic ultrasound in children’s pancreaticobiliary disorders.The PAC-SYM questionnaire for chronic constipation: defining the minimal important difference.Response to letter to the editor by Dr. Villanacci: toward optimal processing of endoscopic submucosal dissection specimens.A hard nut to crack: Bouveret's syndrome.Clinical and morphological characteristics of sporadic genetically determined pancreatitis as compared to idiopathic pancreatitis: higher risk of pancreatic cancer in CFTR variants.Recanalization of a complete postradiation esophageal obstruction with endoscopic submucosal dissection techniques.Endoscopic features of lymphoproliferative diseases.Comparison of side-viewing duodenoscope and single-balloon enteroscope to perform ERCP in patients with Billroth II gastrectomyComparative analysis of ESD versus EMR in a large European series of non-ampullary superficial duodenal tumorsESD versus EMR in non-ampullary superficial duodenal tumors: a systematic review and meta-analysisCombined excision and ablation of ampullary tumors with biliary or pancreatic intraductal extension is effective even in malignant neoplasmsPrevalence and impact of self-reported irritable bowel symptoms in the general population.A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, and tolerability of long-term treatment with prucaloprideLumen restoration of long esophageal strictures. Should we shift towards endoscopic submucosal dissection?Clinical and pharmacogenetic determinants of 5-fluorouracyl/leucovorin/irinotecan toxicity: Results of the PETACC-3 trialRadiomics Response Signature for Identification of Metastatic Colorectal Cancer Sensitive to Therapies Targeting EGFR PathwayImpact of Variability in Portal Venous Phase Acquisition Timing in Tumor Density Measurement and Treatment Response Assessment: Metastatic Colorectal Cancer as a Paradigm[An unusual case of olmesartan induced enteropathy]Risk factors for conversion to snare resection during colorectal endoscopic submucosal dissection in an expert Western centerReply to Chandra et alEndoscopic management of biliary leaks: a systematic review with meta-analysisEndoscopic features, pathological correlates and possible origin of foveolar gastric metaplasia presenting as a duodenal polypAutomated Identification of Optimal Portal Venous Phase Timing with Convolutional Neural NetworksPrevalence and impact of self-reported painful and non-painful constipation in the general populationHow to predict and achieve success with a very long procedure in an endoscopy unit: Is it time for a break?
P50
Q36377218-2A9F9B09-C30C-4AF8-84C2-F0D9C89F1B5CQ37092661-013C84FD-D1A4-489B-AA8A-32127FD8B26AQ37184174-463B29BA-A7E3-4018-8A8D-0B83755D98A0Q38785365-27D9FC91-2526-482D-86D7-9A1D5BD879D8Q39634951-78423113-4F36-4564-9B58-E0E8213CC8D4Q41434912-6A625AC5-12B7-4CCB-9E35-B175BE01AB36Q42206940-AF87C0BF-CA95-47DB-82C7-7FE8DE9393F8Q47106633-C6D43DE2-1D58-4C30-B84D-783FF0FC739EQ47852722-AEA2BD57-23FA-447A-B728-F1808F2CFA69Q48215878-933ED7B2-1D6C-4DF8-8D3F-A85490582F33Q50086437-41E7F981-A5B8-43A9-BAC5-51B5BF140B8DQ50921436-F519DAAD-42AF-449D-BB11-12572542406EQ53548481-71F06C85-AA34-42DE-8851-24498AE94267Q53563425-7BB54F95-41FF-48B7-828D-3B28EDADA576Q57125518-1EBCB874-5DC7-42B6-9729-35AD777D4AB5Q58802468-70577601-8EA8-440B-B241-E51229E45425Q58802471-4630E875-1F22-49C2-A9A1-E606F8F6D9D1Q64229859-464619BA-3206-4E6B-B700-A7122CDF8FD9Q64950691-85087F42-81E7-4C6E-AEE4-B3DC96984A38Q86990828-4634576D-EB6C-41A4-9F74-1657D43EE257Q88417424-9091FA22-986C-4DBC-AF74-7D73130AEFD8Q89125694-F10BA6EA-A135-4FE8-84A2-C56F898052A1Q89522016-87B9F3BB-2ED4-4DC5-A219-DC1C6A064284Q91108593-3996EE18-4456-4094-AF0D-7B7AA5BDAED4Q91322006-26DFB937-09E8-41D5-A4A4-918D2A5D2205Q91396927-989E3654-C02D-4EF9-9C0A-86098E84940BQ91490133-26A88E29-F0C1-4DAD-961F-F06BD5908D09Q91548638-AAD6E900-61AE-44F7-AA11-F9349683EDDEQ91955347-59A92FA9-9025-431E-A9C9-237F0EDC620EQ92450269-8014F995-565C-4ABB-80E5-B8D1D9BDBE16Q92895337-8F2FDB7E-DFCB-4095-A8A4-996BC8921073Q93074275-CDA72894-03D5-49E1-ADBA-82F11889A969
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Hubert Piessevaux
@en
Hubert Piessevaux
@nl
type
label
Hubert Piessevaux
@en
Hubert Piessevaux
@nl
prefLabel
Hubert Piessevaux
@en
Hubert Piessevaux
@nl
P31
P496
0000-0003-1193-0601